Introduction
H yperglycemia has been shown to be deleterious to critically ill patients. 1 Various studies have shown a direct relationship between hyperglycemia and infection, need for renal replacement therapy, ventilatory support, blood transfusion, and mortality in both the short and long term. [2] [3] [4] More specifically, in postoperative cardiac surgery patients, elevated blood glucose (BG) has been linked to increased incidence of deep sternal wound infections, all-cause infection and sepsis, and mortality. [5] [6] [7] [8] [9] As a result of the convincing data on the benefits of glycemic control in postoperative cardiac surgery patients and in an effort to improve adherence to evidence-based guidelines, the Surgical Care Improvement Project (SCIP) established reporting of 6 am BG levels on postoperative days (POD) 1 and 2 for all cardiac surgery patients, requiring values of £ 200 mg/dL for compliance. [10] [11] [12] In an effort to meet SCIP standards and provide better care for patients by more reliably controlling postoperative BG, many hospitals have adopted intravenous (IV) insulin infusion protocols (IIP) rather than relying on subcutaneous 1 Hospital of the University of Pennsylvania, Philadelphia, PA. 2 Thomas Jefferson University Hospital, Philadelphia, PA. 3 Johns Hopkins University, Baltimore, MD. 4 University of Colorado. This research was performed at Thomas Jefferson University Hospital, Philadelphia, PA.
(SQ) insulin, as IIPs appear to more reliably control blood sugars. 13, 14 Justification for maintenance of euglycemia by SCIP centers on the relationship of hyperglycemia to morbidity and mortality. 15, 16 Interestingly, as solid as the evidence is for the benefit of postoperative euglycemia in open heart surgery patients, there appears no evidence that 2 randomly chosen morning blood sugars reflect this degree of glycemic control. To this point, the specific SCIP metric reported herein is based on a theoretical relationship not addressed by the literature.
Our university hospital cardiac surgical program found itself able to uniformly meet all SCIP reported metrics at the top 10% of hospitals in the country except for BG control, for which it was inexplicably at the 50 th percentile. Confounded by this, the authors hypothesized that the mediocre performance resulted from a failure to strictly implement our IIP; specifically, that its utilization was inconsistent and BG assessments were not performed at the required frequency. Secondly, given that the reporting of 6 am BG as a marker of overall glycemic control had no justification in the literature, the authors recognized that while testing that hypothesis, they had the opportunity to address the question of whether the SCIP metric of 6 am BG was, in fact, reflective of overall glycemic control during the early postoperative period. They specifically hoped that this single-center study might generate further hypotheses and research on this subject and the subject of reported metrics in general.
Methods

Study design
The authors conducted a retrospective chart review of 140 consecutive postoperative heart surgery patients admitted to the surgical cardiac care unit in our academic, quaternary care hospital between September 1, 2007 and October 1, 2008. Patients qualifying for the study had postoperative orders for our hospital's IIP. Patients were excluded if they were not receiving insulin IV on POD 1 at 6 am, as the primary purpose of the study was to examine the reasons patients on an IIP might fail to meet the SCIP metric. Furthermore, patients who died prior to POD 2 or who had missing descriptive data were excluded. This resulted in 99 eligible patients upon whom this study was based. The change in the insulin infusion rate determined by the IIP algorithm involved both realtime BG level and the change in BG from the previous hour. We used the capillary blood glucose sample reported in the medical record for all data analysis as (a) SCIP utilizes this manner of glucose measurement for its report, and (b) as stated above, our protocolized insulin adjustments are based on this measurement. BG was targeted at 80-140 mg/dL. The decision to transition to insulin SQ on POD 1 was determined by the attending. The insulin SQ regimen for each patient was based on the quantity of insulin that the patient received over the immediately previous euglycemic period, and followed the guidelines of the American Diabetes Association. 17 Evaluation of SCIP 6 am BG POD 1 and 2 as a surrogate of euglycemia To evaluate the appropriateness of using ''6 am BG on POD 1 and 2'' as a surrogate for glycemic control, the authors compared the SCIP compliant group (Group 1, defined as those patients with BG £ 200 mg/dL at 6 am on both POD 1 and 2) to the SCIP noncompliant group (Group 2, defined as those patients with BG > 200 mg/dL at 6 am on either POD 1 or 2). They examined each group's average BG over the measured 48-hour period, the number of episodes of BG > 200 mg/dL, the percent time with BG > 200 mg/dL, and performed a linear regression analysis to relate each patient's 6 am BG with his or her average BG over the course of the study period. The BG measurement taken closest to 6 am was used as the 6 am BG, per the SCIP definition.
Total time of BG monitoring was defined as the first 48 postoperative hours, beginning with the time of the first BG check on POD 0. Time with BG > 200 mg/dL (hyperglycemic) was determined such that if 1 BG measure was > 200 mg/dL and the next measure was BG £ 200 mg/dL, the entire time between measurements was viewed as hyperglycemic; when a BG was not hyperglycemic followed by one that was, that interim period was viewed as not hyperglycemic. Hyperglycemic time was expressed as a percent of the total time of BG monitoring. The authors additionally counted both the number of hypoglycemic and hyperglycemic episodes, defined as any BG < 70 mg/dL and BG > 200 mg/dL, respectively. However, if a patient met the requirements for a hypoglycemic or hyperglycemic episode, adjacent noneuglycemic values did not count as separate episodes (ie, multiple adjacent BG > 200 mg/dL values did not count as separate episodes).
Factors associated with SCIP compliance
Baseline patient and postoperative characteristics were compared for Groups 1 and 2. The Fisher exact test was used to compare categorical variables; continuous variables were compared using the Kruskal-Wallis test.
Potential risk factors of SCIP noncompliance included age, obesity, sex, epinephrine infusion, history of diabetes mellitus (DM), intensity of implementation of the IIP, defined as number of assessments of the insulin infusion rate per hour, and switching to insulin SQ prior to 6 am on POD 2. Logistic regression was used to evaluate the relationship between SCIP noncompliance and these potential risk factors. Additionally, we compared those patients who transitioned to insulin SQ prior to 6 am on POD 2 versus those who remained on the IIP through 6 am on POD 2.
As a point of clarification, the number of BG assessments per hour while on the IIP was used as a marker for intensity of IIP implementation. If a patient had 10 assessments over 20 hours, the intensity of IIP implementation would be 0.5; the intensity of IIP implementation for a patient with 20 assessments in 20 hours would be 1.0.
Significance was determined by a P value < 0.05 by univariate and multivariate analyses. Statistical analyses were performed using SAS software, version 9.1 (SAS Institute Inc, Cary, NC).
This study was approved by each organization's Institutional Review Board. 5000 BG checks measured in this study, there were 18 episodes of hypoglycemia (BG < 70 mg/dL) in 15 patients, although no patient was symptomatic of hypoglycemia.
Results
Group
Blood glucose characteristics of study groups Group 1 had a lower overall mean BG compared to group 2, a lower mean BG on the IIP (147 mg/dL vs. 193 mg/dL), a lower percent time in a hyperglycemic state, and fewer episodes of hyperglycemia over the measured 48-hour period (P £ 0.0001 for all) ( Table 1) .
Furthermore, POD 1 and 2 BG were reliable metrics reflective of overall BG in that a patient's mean BG over the 48-hour study period was related to his POD 1 or 2 BG by linear regression (BG mean = 0.94 [6 am BG POD 1], BG mean = 0.96 [6 am BG POD 2]; P < 0.0001).
Factors associated with SCIP noncompliance
Both the univariate and multivariate analyses show that Groups 1 and 2 were similar regarding age, sex, and receipt of epinephrine infusion (Table 2) . By univariate analysis, switching to insulin SQ was a risk factor for noncompliance. Group 2 switched to insulin SQ prior to 6 am on POD 2 more frequently (85%) compared to group 1 (61%) (P = 0.05). Even more striking, no patient maintained on insulin IV through 6 am on POD 2 had a BG > 200 mg/dL that morning. Specifically, 34 of 34 patients on the IIP were SCIP compliant on POD 2, whereas only 55 of 65 patients who had switched to insulin SQ were compliant on POD 2 (P = 0.01). Also by univariate analysis, DM and obesity were significant risk factors for SCIP noncompliance (P = 0.003 and P = 0.04, respectively). Of the patients with diabetes in the study, only 63% were SCIP compliant compared to 89% of nondiabetics. Finally, in that the intensity of IIP implementation was not different between groups, SCIP noncompliance was not the result of provider inattention. In fact, the trend was for more assessments in the noncompliant group. (Group 1: 0.62 assessments/hour; Group 2: 0.72 assessments/hour; P = 0.25).
By multivariate analysis, obesity ceased to be a predictor of SCIP noncompliance, but DM and switching to insulin SQ continued to be. Of note, by stepwise multivariate analysis, if DM was not present, obesity then became a significant risk factor. As with the univariate analysis, switching to insulin SQ prior to 6 am on POD 2 continued to be a risk factor for SCIP noncompliance. As already indicated, every patient maintained on insulin IV was compliant on POD 2.
Discussion
The evidence of the benefit of glycemic control in postoperative cardiac surgery patients has been consistent.
5,7-9,18,19 In these studies, glycemic control has led to improved outcomes when BG has been kept in the 150-170 mg/dL range as compared to >200 mg/dL. Coincident with these findings regarding BG and postoperative wound infections, it has become apparent that protocols and checklists that ''force'' physician behavior reduce medical errors and improve quality of care, [20] [21] [22] [23] and many hospitals have instituted insulinglucose algorithms to good effect. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] However, our experience in instituting an IIP was less successful; in particular, as evidenced by our inability to consistently meet the SCIP metric of BG £ 200 mg/dL on POD 1 and 2 at 6 am. We initially hypothesized that erratic implementation of our IIP, which aimed for a BG of < 140 mg/dL, was responsible for our inability to dependably prevent hyperglycemia. To the contrary, our findings showed that poor BG control in the SCIP noncompliant group occurred in the face of a trend toward an increased number of BG assessments. A variety of published studies appear to mirror our experience; specifically, one uniform IIP is not effective for all patients, [34] [35] [36] and when it fails, it fails in patients with diabetes. 37 The data also showed that all instances of noncompliance on POD 2 were in patients on insulin SQ, while every patient on insulin IV on POD 2 was compliant, regardless of risk *By stepwise multivariate analysis, in the absence of DM, obesity is a significant risk factor for SCIP noncompliance with an odds ratio 3.27, 95% confidence interval (CI) 1.05 -10.18, P = 0.04. DM, diabetes mellitus; Epi, epinephrine infusion; IIP, insulin infusion protocol; Ins, insulin, SCIP, Surgical Care Improvement Project; SQ, subcutaneous.
factors. Interestingly, 9 of the 10 noncompliant patients on POD 2 had diabetes and the nondiabetic patient was obese. It seems clear from this study that transitioning patients with DM or obesity to insulin SQ prior to POD 2 is ill advised if hyperglycemia is to be avoided.
Although picking a moment in time to report BG measurement makes perfect sense as a metric hospitals could be expected to report, the SCIP utilization of 6 am POD 1 and 2 BG as a surrogate for overall glycemic control is without supporting evidence. 15, 16 Our paper is the first of which we are aware to document the association between this SCIP metric and overall glycemic control. It also is interesting to remark that while individual 6 am BGs were highly correlated with an individual patient's mean BG, the 6 am value is consistently higher than the mean BG (BG mean = 0.94 [6 am BG POD 1], BG mean = 0.96 [6 am BG POD 2]; P < 0.0001). In that the 6 am time point represents a BG that is higher than the patient's mean, it becomes a more sensitive measure for glycemic control. Further support of this SCIP metric as reflective of hyperglycemia is illustrated by the fact that during the first 2 postoperative days, almost 40% of the time Group 2 patients were hyperglycemic. Prior studies have not looked at this metric, 2, 5 but we found it striking that the duration of hyperglycemia was so different between the 2 groups.
Finally, we would like to highlight an issue of significant importance that is ignored by the SCIP guidelines. By targeting a lower blood sugar, SCIP may inadvertently be increasing the incidence of hypoglycemia. In this study, 15 patients experienced BG < 70 mg/dL, the vast majority (80%) of whom were in the SCIP compliant group. In the recent NICE-SUGAR Study, which targeted a tightly controlled BG of 80-110 mg/dL, investigators reported a hypoglycemia rate of 6.8% (BG < 40 mg/dL), 38 with an increased mortality in that group related solely to the deaths in the hypoglycemic subpopulation. Thus, while it is true that hyperglycemia in postoperative cardiac surgery patients increases morbidity and mortality, it is also clear that tight BG control puts patients at risk for hypoglycemia, with its own associated morbidity and mortality. [39] [40] [41] We contend that SCIP should require concurrent reporting of hypoglycemia, an unintended consequence of BG control, as it is at least of equal if not more importance to patient outcomes than hyperglycemia. Although none of our patients experienced hypoglycemia to the degree seen in the NICE-SUGAR Study, virtually all of the patients who experienced BG < 70 mg/dL fell in the SCIP compliant group. Aiming for SCIP compliance may inadvertently make hypoglycemia an issue for this population, and safeguarding against that by requiring its report is advisable.
We would be remiss if we did not acknowledge that SCIP metrics have become an indicator of hospital performance for all of us who care for surgical patients. 42 Adherence to SCIP metrics is now viewed as synonymous with quality of care. 16, 43 Publicly reporting compliance with SCIP guidelines on Web sites such as Hospital Compare.org 43 is designed to help consumers make choices regarding hospitals. Viewed in this manner, compliance with SCIP metrics has become much more than simply an attempt to diminish postoperative wound infections or other complications, but a way for our hospitals to assure the public that they are being well served. The choice of metrics required by SCIP for public reporting is arguably even more important, when viewed in this manner, as they no longer simply reflect perioperative care but are much more far-reaching.
The authors recognize that a weakness of this study is its size and retrospective design. Furthermore, recent data show the capillary blood glucose sample may not perfectly correlate with serum glucose levels. 44, 45 Yet, the findings are significant and striking, and we feel accurately reflect the problems hospitals face in carrying out glucose control for cardiac surgery patients in the early postoperative period. Furthermore, during the analysis of this study, we recognized that by emphasizing only control of hyperglycemia, SCIP may be fostering unwanted, unmeasured morbidity in this population. Future investigation should continue to examine improved tools to prevent hyperglycemia in postoperative patients, but with the caveat that we must simultaneously determine to what degree hypoglycemia occurs as a result.
Conclusion
This study shows that a single uniform IIP may not be effective to treat all intensive care unit patients, particularly postoperative cardiac surgery patients with DM and obesity. Furthermore, transition to insulin SQ should not occur prior to POD 2, especially in those 2 classes of patients, as they represent the highest risk for SCIP noncompliance. Finally, whether by luck or by design, 6 am BG on POD 1 and 2 significantly correlates with postoperative hyperglycemia (BG > 200 mg/dL) as measured by mean BG, percent time > 200 mg/dL, and number of episodes > 200 mg, supporting its use as a marker for glycemic control. Nevertheless, it is apparent that the SCIP focus on hyperglycemia, while ignoring the incidence of hypoglycemic events, may have unintended, deleterious consequences. In this respect, our study points out the need for continued assessment of publicly reported metrics, to critically evaluate them as adequate surrogates for quality of care, assuring that adherence to them is without unintended, adverse consequences.
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